Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.
Press releases published on July 9, 2025
Bitget Partners With UNTOLD Festival, Where Web3 Takes The Main Stage
GlobeNewswire
·
July 9, 2025
Bitget headlines the global stage as UNTOLD’s exclusive Web3 partner CLUJ-NAPOCA, Romania, July 09, 2025 (GLOBE NEWSWIRE) -- Bitget, the world’s leading cryptocurrency exchange and Web3 company, has collaborated with UNTOLD - one of the top three music …
XRP Mining Introduces Hassle-Free Mobile Cloud Mining App For Earning Crypto Daily
GlobeNewswire
·
July 9, 2025
Chicago, Illinois, July 09, 2025 (GLOBE NEWSWIRE) -- Let’s be honest — traditional crypto mining is a serious commitment:You’ll need high-end hardware that can cost thousands.Electricity bills can skyrocket.The noise and heat from mining rigs? A nightmare. …
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
GlobeNewswire
·
July 9, 2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory …
Surge Copper Announces Upsize of Private Placement to $10.4 Million
GlobeNewswire
·
July 9, 2025
Not for distribution to U.S. newswire services or dissemination in the United States Vancouver, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to …
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
GlobeNewswire
·
July 9, 2025
Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“ …
Bitget Integrates xStocks to Bring Wall Street to Web3 with Tokenized Stocks on Onchain
GlobeNewswire
·
July 9, 2025
VICTORIA, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has introduced support for tokenized stocks via its Onchain platform, following an integration with xStocks that bridges traditional …
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
GlobeNewswire
·
July 9, 2025
Article Indicates that Inhibition of PP2A Enhances Immunotherapy Response with LIXTE’s Proprietary Compound LB100 PASADENA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a …
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
GlobeNewswire
·
July 9, 2025
Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidates Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services …
Amneal to Report Second Quarter 2025 Results on August 5, 2025
GlobeNewswire
·
July 9, 2025
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on …
Benitec Biopharma Provides Operational Updates
GlobeNewswire
·
July 9, 2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been Completed for All Six Subjects …
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of Sergio Traversa, PharmD, as an Independent Director to its …
Sonoro Gold PROVIDES AN UPDATE ON THE ENVIRONMENTAL PERMIT (mia) FOR THE CERRO CALICHE GOLD PROJECT
GlobeNewswire
·
July 9, 2025
VANCOUVER, Canada, July 09, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to provide an update on the status of the Environmental Impact Statement, or Manifestacion de Impacto …
Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity
GlobeNewswire
·
July 9, 2025
-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …
Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)
GlobeNewswire
·
July 9, 2025
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential …
Amerigo Reports Q2-2025 Operational Results
GlobeNewswire
·
July 9, 2025
Q2-2025 copper production of 15.5 million pounds 2025 production and cash cost1 guidance remain in place $7.6 million returned through Share Buybacks and Dividends in Q2-2025 VANCOUVER, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources …
Class 1 Nickel Commences 2025 Exploration Program at the River Valley PGE-Cu-Ni Project, Ontario, Canada
GlobeNewswire
·
July 9, 2025
TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Class 1 Nickel and Technologies Limited (CSE: NICO | OTCQB: NICLF) ("Class 1” or the "Company") is pleased to announce the launch of its 2025 summer exploration program on its 100%-owned River Valley PGE-Cu-Ni …
Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD)
GlobeNewswire
·
July 9, 2025
GAITHERSBURG, Md., July 09, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has enrolled the …
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
GlobeNewswire
·
July 9, 2025
NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- …
Brunswick Exploration Has Now Identified Four Major New Dykes in 2025 at Mirage
GlobeNewswire
·
July 9, 2025
MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report the final set of results obtained as part of the 2025 Winter drill campaign conducted on its Mirage Project. The …
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
GlobeNewswire
·
July 9, 2025
– John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor – – Dr. Houston to Remain Chairperson of Arvinas Board of Directors – – Arvinas Board of Directors to Lead Search for CEO …